Stem cells offer new therapeutic avenues for the repair and replacement of damaged tissues
and organs owing to their self-renewal and multipotent differentiation capabilities. In this …

Background Continuous-flow left ventricular assist device (CF-LVAD) support is a mainstay
in the hemodynamic management of patients with end-stage heart failure refractory to …

Abstract Background In October 2018, the United States implemented a change in the donor
heart allocation policy from a three-tiered to a six-tiered status system. The purpose of the …

OBJECTIVES Malignancy is the leading cause of late mortality after orthotopic heart
transplantation (OHT), and the burden of post-transplantation cancer is expected to rise in …

Deafness is the most common neurological disorder in humans, which has seriously
affected the normal life of human beings. According to the World Hearing Report published …

In this issue of the Journal, Bakir and colleagues 6 investigate acute cellular rejection (ACR)
incidence in a propensity-matched cohort of patients who had undergone HT with or without …

Rejekce je významnou komplikací po transplantaci a také za jeden z hlavních důvodů ztráty
funkce štěpu. Je vyvolána odpovědí imunitního systému příjemce orgánu na základě setkání …

Objectives We compared posttransplant outcomes between patients bridged from temporary
mechanical circulatory support to durable left ventricular assist device before transplant …

The interplay between left ventricular assist devices (LVADs) and the immune system is a
dynamic area of continued investigation. In the era of continuous-flow LVADs, interactions …

Bakir and colleagues 1 report a robust analysis of rejection following support with a
continuous-flow (CF) left ventricular assist device (LVAD), which provides convincing …